BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29166413)

  • 1. Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases.
    Manojlovic Z; Christofferson A; Liang WS; Aldrich J; Washington M; Wong S; Rohrer D; Jewell S; Kittles RA; Derome M; Auclair D; Craig DW; Keats J; Carpten JD
    PLoS Genet; 2017 Nov; 13(11):e1007087. PubMed ID: 29166413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent.
    Levine AJ; Carpten JD; Murphy M; Hainaut P
    Cell Death Differ; 2024 Jan; 31(1):1-8. PubMed ID: 38001255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker.
    Ryu D; Kim HJ; Joung JG; Lee HO; Bae JS; Kim SJ; Kim H; Park WY; Kim K
    Oncotarget; 2016 Jul; 7(30):47127-47133. PubMed ID: 27223072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
    Lee MJ; Koff JL; Switchenko JM; Jhaney CI; Harkins RA; Patel SP; Dave SS; Flowers CR
    Cancer; 2020 Aug; 126(15):3493-3503. PubMed ID: 32469082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.
    Kazandjian D; Hill E; Hultcrantz M; Rustad EH; Yellapantula V; Akhlaghi T; Korde N; Mailankody S; Dew A; Papaemmanuil E; Maric I; Kwok M; Landgren O
    Blood Cancer J; 2019 Feb; 9(2):15. PubMed ID: 30718460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic deep-targeted next-generation sequencing assessment of TP53 gene mutations in multiple myeloma from the whole bone marrow.
    Petrackova A; Minarik J; Sedlarikova L; Libigerova T; Hamplova A; Krhovska P; Balcarkova J; Pika T; Papajik T; Kriegova E
    Br J Haematol; 2020 May; 189(4):e122-e125. PubMed ID: 32130732
    [No Abstract]   [Full Text] [Related]  

  • 8. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
    van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
    Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF4 addiction in multiple myeloma.
    Shaffer AL; Emre NC; Lamy L; Ngo VN; Wright G; Xiao W; Powell J; Dave S; Yu X; Zhao H; Zeng Y; Chen B; Epstein J; Staudt LM
    Nature; 2008 Jul; 454(7201):226-31. PubMed ID: 18568025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120.
    Dhodapkar MV; Sexton R; Hoering A; Van Rhee F; Barlogie B; Orlowski R
    Clin Cancer Res; 2020 Nov; 26(22):5814-5819. PubMed ID: 32816893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences and functional analysis of MET mutations in lung cancer.
    Krishnaswamy S; Kanteti R; Duke-Cohan JS; Loganathan S; Liu W; Ma PC; Sattler M; Singleton PA; Ramnath N; Innocenti F; Nicolae DL; Ouyang Z; Liang J; Minna J; Kozloff MF; Ferguson MK; Natarajan V; Wang YC; Garcia JG; Vokes EE; Salgia R
    Clin Cancer Res; 2009 Sep; 15(18):5714-23. PubMed ID: 19723643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
    Bolli N; Avet-Loiseau H; Wedge DC; Van Loo P; Alexandrov LB; Martincorena I; Dawson KJ; Iorio F; Nik-Zainal S; Bignell GR; Hinton JW; Li Y; Tubio JM; McLaren S; O' Meara S; Butler AP; Teague JW; Mudie L; Anderson E; Rashid N; Tai YT; Shammas MA; Sperling AS; Fulciniti M; Richardson PG; Parmigiani G; Magrangeas F; Minvielle S; Moreau P; Attal M; Facon T; Futreal PA; Anderson KC; Campbell PJ; Munshi NC
    Nat Commun; 2014; 5():2997. PubMed ID: 24429703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical Artery Dissection in Patients of African Ancestry.
    Green IE; Rahman SA; Owens DL; Sale MM; Currie LJ; Keene KL; Worrall BB; Southerland AM
    Cerebrovasc Dis; 2018; 46(5-6):218-222. PubMed ID: 30517918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.
    Araujo LH; Timmers C; Bell EH; Shilo K; Lammers PE; Zhao W; Natarajan TG; Miller CJ; Zhang J; Yilmaz AS; Liu T; Coombes K; Amann J; Carbone DP
    J Clin Oncol; 2015 Jun; 33(17):1966-73. PubMed ID: 25918285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and multiple myeloma among black and white men: evidence of a genetic association.
    Pottern LM; Gart JJ; Nam JM; Dunston G; Wilson J; Greenberg R; Schoenberg J; Swanson GM; Liff J; Schwartz AG
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):177-82. PubMed ID: 1306102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.
    Baker A; Braggio E; Jacobus S; Jung S; Larson D; Therneau T; Dispenzieri A; Van Wier SA; Ahmann G; Levy J; Perkins L; Kim S; Henderson K; Vesole D; Rajkumar SV; Jelinek DF; Carpten J; Fonseca R
    Blood; 2013 Apr; 121(16):3147-52. PubMed ID: 23422747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
    Baliñas-Gavira C; Rodríguez MI; Andrades A; Cuadros M; Álvarez-Pérez JC; Álvarez-Prado ÁF; de Yébenes VG; Sánchez-Hernández S; Fernández-Vigo E; Muñoz J; Martín F; Ramiro AR; Martínez-Climent JA; Medina PP
    Leukemia; 2020 Oct; 34(10):2722-2735. PubMed ID: 32576963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
    Kytola V; Topaloglu U; Miller LD; Bitting RL; Goodman MM; D Agostino RB; Desnoyers RJ; Albright C; Yacoub G; Qasem SA; DeYoung B; Thorsson V; Shmulevich I; Yang M; Shcherban A; Pagni M; Liu L; Nykter M; Chen K; Hawkins GA; Grant SC; Petty WJ; Alistar AT; Levine EA; Staren ED; Langefeld CD; Miller V; Singal G; Petro RM; Robinson M; Blackstock W; Powell BL; Wagner LI; Foley KL; Abraham E; Pasche B; Zhang W
    Theranostics; 2017; 7(11):2914-2923. PubMed ID: 28824725
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.